This indicates that IL-6 may contribute to the pathogenesis of CSX by promoting inflammation and initiating endothelial dysfunction, which leads to reduced vascular reactivity, specifically microvascular vasoconstriction. Here, IL6 is linked to endothelial dysfunction.